Page 1 – Challenge
| Q1. Major finding(s) |
|---|
| ☐ Complete left hemithorax opacification with volume loss |
| ☐ Large left pleural effusion with mediastinal shift to the right |
| ☐ Unilateral hyperlucent lung with vascular attenuation |
| ☐ Bilateral perihilar ground-glass opacities |
| Q2. Associated finding(s) |
|---|
| ☐ Tracheal deviation toward the left hemithorax |
| ☐ Elevation of the left hemidiaphragm |
| ☐ Rib crowding on the left side |
| ☐ Hyperinflation of the right lung with mediastinal shift toward the left |
2. Findings
Q1 Major Findings:
| Option | Finding |
|---|---|
| ☐ | Complete left hemithorax opacification with volume loss |
| ☐ | Large left pleural effusion with mediastinal shift to the right |
| ☐ | Unilateral hyperlucent lung with vascular attenuation |
| ☐ | Bilateral perihilar ground-glass opacities |
Q2 Associated Findings:
| Option | Finding |
|---|---|
| ☐ | Tracheal deviation toward the left hemithorax |
| ☐ | Elevation of the left hemidiaphragm |
| ☐ | Rib crowding on the left side |
| ☐ | Hyperinflation of the right lung with mediastinal shift toward the left |
Introduction:
A 62-year-old female presents with acute dyspnea and left-sided chest pain. One month after initial imaging, a frontal chest radiograph demonstrates complete opacification of the left hemithorax. Subsequent workup revealed a small cell lung carcinoma obstructing the left mainstem bronchus, producing post-obstructive atelectasis and associated volume loss.
Findings:
| Type | Feature | Definition / Note |
|---|---|---|
| Primary | Left hemithorax “white out” | Complete radiographic opacification due to atelectasis; indicates major airway obstruction or large pleural effusion. |
| Primary | Obstructing mass in left mainstem bronchus | Soft tissue lesion causing bronchial occlusion; typical of central small cell lung carcinoma. |
| Associated | Mediastinal shift toward opacified side | Compensatory shift due to volume loss from collapse; absent in pleural effusion (shifts away). |
| Associated | Elevation of left hemidiaphragm | Sign of lobar or total lung collapse. |
| Associated | Compensatory hyperinflation of right lung | Adaptive overexpansion to maintain ventilation; absent in bilateral disease. |
Differential Diagnosis:
| Condition | Imaging Clues | Notes / Differentiating Features |
|---|---|---|
| Obstructive Atelectasis (e.g., Small Cell Lung Carcinoma) | Ipsilateral mediastinal shift, volume loss, elevated hemidiaphragm, vascular crowding | Central mass obstructing main bronchus; rapid onset of dyspnea; progressive opacification. |
| Non-Small Cell Lung Carcinoma (NSCLC) | Central or peripheral mass, volume loss if central; possible secondary effusion | Usually slower progression than SCLC; peripheral nodules more common in adenocarcinoma. |
| Massive Pleural Effusion (benign or malignant) | Homogeneous opacity, mediastinal shift away from affected side, meniscus sign | May be caused by CHF, infection, or malignancy; confirmed with lateral decubitus or ultrasound. |
| Acute Lobar Pneumonia / Post-obstructive Pneumonitis | Air bronchograms, segmental/lobar opacification | Fever, leukocytosis, productive cough; may follow airway obstruction from tumor. |
| Total Lung Collapse from Mucous Plug | Ipsilateral mediastinal shift, volume loss, elevated diaphragm | Rapid onset; often reversible after bronchoscopy; no mass on imaging. |
| Congestive Heart Failure (Unilateral Pulmonary Edema) | Opacification, usually right but can be left; vascular redistribution, Kerley B lines; possible cardiomegaly | Often associated with acute dyspnea, elevated BNP; improves with diuretics. |
| Massive Pulmonary Hemorrhage | Diffuse opacity, may spare periphery; rapid onset | Hemoptysis prominent; acute anemia possible; usually bilateral but can be unilateral. |
| Chronic Fibrotic Lung or Lung Hypoplasia | Volume loss, opacification, mediastinal shift | Usually long-standing; asymptomatic; identified by prior imaging. |
By Images:
27295c.jpg : Atelectasis of the Left Lung, Pleural Effusion, Pericardial Tamponade s/p AVR 60 year old male s/p AVR presents with acute respiratory distress. CT scan shows total collapse of left lung, associated with a large effusion The atelectasis is either due to the associated effusion or an obstructing mucus plu. There is a large pericardial effusion with tamponade physiology by echo Ashley Davidoff MD TheCommonVein.net
4945449454.jpg : Pleural Effusions – Compressive Atelectasis keywords lung pleura effusions bilateral pleural effusions compressive atelectasis left atrial enlargement coronary artery calcification congestive heart failure CHF CTscan Ashley Davidoff MD TheCommonVein.net 49454
86265c02.8s.jpg : 86265c02.8s This a plain film and a CT of a 61 year male with non small cell carcinoma treated 9 months prior and a recent admission to an outside institution with MRSA. he was transferred to current hospital due to worsening blood gases and CTA showed complete occlusion of the left pulmonary artery. Dopller showed DVT of the right popliteal vein. He had a subsequent episode of worsening of blood gases and a chest X-ray showed a complte white out of the right lung and a mid region (upper triangle in b) of a paucity of blood vessels. This is known as Westermark’s sign. The white out on the right side was thought to be due to aspiration. He thus had no ventilation of the right lung and almost no perfusion of the left lung. He was bronchoscoped and thick secretions were removed from the right bronchus. Despite treatment on anticoagulants and repeated bronchospies he expired. lung bronchus Westermark’s sign PE pulmonary embolus massive aspiration pneumonia CTscan chest X-ray CXR Courtesy Ashley Davidoff MD copyright 2009 all rights reserved
b79788-00 62M SOB lungs largeR pleural effusion dx DDx NSCLC CXR frontal : Moderate Right Pleural Effusion – Chest X-Ray (Frontal) Chest radiograph of a 62-year-old man with shortness of breath shows a moderate right-sided pleural effusion, occupying approximately half the hemithorax. There is blunting of the right costophrenic angle and a meniscus sign, without complete white-out. In this patient, the unilateral moderate effusion raises concern for malignant etiology, particularly non–small cell lung carcinoma (NSCLC). Other differential considerations include infection such as tuberculosis or parapneumonic effusion, though the clinical setting favors malignancy. This case illustrates the classic appearance of a moderate pleural effusion—an opacity rising to mid-chest with volume effect—highlighting the importance of correlating radiographic findings with clinical context to guide differential diagnosis. Ashley Davidoff MD – TheCommonVein.com (b79788-00
74F-scleroderma-reflux-aspiration-pneumonia-001-white-out.jpg : Scleroderma Aspiration and a Whiteout 74 year old female with scleroderma presents with hyperacute respiratory distress A CXR shows an acute white out of the left hemithorax and a right lower lobe infiltrate. There is mediastinal shift to the left suggesting left sided volume loss consistent with obstructive atelectasis and likely die t ongoing aspiration Ashley Davidoff MD TheCommonVein.net 74F scleroderma reflux aspiration pneumonia 001 white out
Pearls:
| Pearl | Detail |
|---|---|
| Obstructive “white out” | Central tumors causing lobar or total lung collapse can mimic pleural effusion; look for mediastinal shift. |
| Small cell pattern | Typically central, aggressive, with rapid growth; uncommon to present as peripheral mass. |
| Atelectasis signs | Volume loss indicators include ipsilateral mediastinal shift, diaphragm elevation, and crowding of pulmonary vessels. |
Comments:
| Comment | Detail |
|---|---|
| Clinical correlation essential | Imaging alone cannot distinguish tumor from mucous plug in acute collapse; consider history and timing. |
| Radiographic follow-up | Progressive “white out” over weeks is typical of rapidly growing small cell carcinoma causing complete bronchial obstruction. |
| Teaching point | Recognize central mass vs pleural effusion: mediastinal shift direction and vascular crowding are key. |
3. Diagnosis
Diagnostic Focus:
| Statement |
|---|
|
In this patient, the left hemithorax “white out” with ipsilateral mediastinal shift and elevated hemidiaphragm indicates complete left lung collapse secondary to an obstructing central mass, consistent with small cell lung carcinoma (SCLC) of the left mainstem bronchus. Imaging and clinical progression support rapid tumor growth, characteristic of SCLC.Clinical Perspective: |
| Aspect | Detail |
|---|---|
| Definition | Small cell lung carcinoma (SCLC) is a highly malignant neuroendocrine tumor arising centrally from bronchial epithelium. |
| Cause / Risk Factors | Strongly associated with cigarette smoking; rare in non-smokers; central bronchial origin. |
| Pathophysiology | Rapid proliferation, central airway obstruction, early metastasis; paraneoplastic syndromes possible (e.g., SIADH, Cushing). |
| Structural Change | Central mass occluding mainstem bronchus; ipsilateral lung collapse; mediastinal shift toward affected side. |
| Functional Impact | Impaired ventilation of affected lung; hypoxemia; dyspnea; risk of post-obstructive infection. |
| Clinical Features | Acute dyspnea, chest pain, cough, possible hemoptysis; systemic symptoms uncommon until advanced. |
| Labs / Biomarkers | Possible elevated LDH, NSE (neuron-specific enolase), Pro-GRP; SIADH in paraneoplastic syndrome. |
| Treatment | Chemotherapy + radiation (mainstay); surgery rare due to central location and early metastasis; supportive care for atelectasis. |
| Prognosis | Poor; median survival months if untreated; responds initially to chemo but relapses quickly. |
Pearls:
| Pearl | Detail |
|---|---|
| Central location | SCLC almost always central; differentiates from peripheral NSCLC. |
| Rapid progression | Hemithorax “white out” can develop in weeks due to fast-growing tumor. |
| Atelectasis vs effusion | Ipsilateral mediastinal shift and crowding of vessels key to differentiate. |
Comments:
| Comment | Detail |
|---|---|
| Radiologic-pathologic correlation | Bronchoscopy and biopsy are required to confirm SCLC; imaging alone suggests but does not confirm histology. |
| Monitor complications | Post-obstructive pneumonia or pleural effusion may coexist. |
| Teaching point | Recognize central SCLC pattern: “white out” with volume loss, not effusion; mediastinal shift direction critical. |
4. Medical History and Culture
Historical and Cultural:
| Topic | Details |
|---|---|
| Etymology | “Carcinoma” → Greek karkinos = crab, describing tumor with finger-like projections; “small cell” refers to histology of small, round, blue cells. |
| AKA | • Oat cell carcinoma• Central small cell carcinoma• SCLC |
| Historical Notes | First described as a distinct pulmonary tumor in 1926; recognized for aggressive course and early metastasis. |
| Cultural Insights | Smoking epidemic in 20th century contributed to SCLC prevalence; central location and rapid progression make it emblematic of tobacco-related malignancies. |
| Notable Figures | • Dr. Jacob Furth – early SCLC pathologist• Dr. Henry Kaplan – pioneering radiation oncologist in lung cancer therapy |
| Quotes | “The lung may conceal its enemy until it has already conquered much of the territory.” – Historical radiology text |
| Optional Poem | In shadowed bronchus, a tiny seed,Grows swift and silent, fulfills its need.A lung’s white veil, a warning shown,Central malignancy, all too known. |
6. MCQs
Part A – Questions
| Q1: Which cellular feature is characteristic of small cell lung carcinoma? |
|---|
| Large polygonal cells with abundant cytoplasm |
| Small round/oval cells with scant cytoplasm |
| Spindle cells with fibrous stroma |
| Signet-ring cells with mucin vacuoles |
| Q2: Which paraneoplastic syndrome is most commonly associated with SCLC? |
|---|
| Hypercalcemia due to PTHrP |
| SIADH leading to hyponatremia |
| Cushing’s syndrome |
| Lambert-Eaton myasthenic syndrome |
| Q3: What is the most common clinical presentation of central small cell lung carcinoma? |
|---|
| Peripheral nodule detected incidentally |
| Acute dyspnea and hemithorax “white out” from airway obstruction |
| Hemoptysis without airway collapse |
| Asymptomatic pleural effusion |
| Q4: Which treatment is standard first-line therapy for extensive-stage SCLC? |
|---|
| Surgical lobectomy |
| Combination chemotherapy ± radiation |
| Targeted EGFR inhibitor |
| Observation alone |
| Q5: On a frontal chest radiograph, which feature helps distinguish obstructive atelectasis from pleural effusion? |
|---|
| Ipsilateral mediastinal shift |
| Crowding of pulmonary vessels |
| Elevation of hemidiaphragm |
| All of the above |
| Q6: Which imaging feature is most indicative of a central obstructing mass? |
|---|
| Peripheral ground-glass opacity |
| Focal pleural thickening |
| Ipsilateral hemithorax opacification with volume loss |
| Bilateral interstitial markings |
| Q7: Which laboratory or biomarker is useful in supporting the diagnosis of SCLC? |
|---|
| CEA |
| CA 19-9 |
| Neuron-specific enolase (NSE) |
| AFP |
Part B – Explanations
| Q1: Cellular feature of SCLC |
|---|
| Small round/oval cells with scant cytoplasm – Typical “oat cell” appearance; hyperchromatic nuclei; high mitotic rate. Reference: Travis et al., WHO Classification of Tumours, 2021 |
| Large polygonal cells – Incorrect, characteristic of non-small cell lung carcinoma (NSCLC). |
| Spindle cells – Incorrect, seen in sarcomatoid carcinoma. |
| Signet-ring cells – Incorrect, more typical of adenocarcinoma with mucin production. |
| Q2: Paraneoplastic syndrome in SCLC |
|---|
| SIADH leading to hyponatremia – Most frequent paraneoplastic syndrome in SCLC due to ectopic ADH secretion. Reference: Travis et al., WHO Classification of Tumours, 2021 |
| Hypercalcemia – Incorrect, more common in squamous cell carcinoma. |
| Cushing’s syndrome – Less frequent; due to ectopic ACTH. |
| Lambert-Eaton – Can occur but less common than SIADH. |
| Q3: Clinical presentation |
|---|
| Acute dyspnea and hemithorax “white out” from airway obstruction – Central mass occluding mainstem bronchus causes atelectasis. Reference: Dr. Michael A. Chansky, Medscape, 2025 |
| Peripheral nodule – Incorrect, peripheral masses are usually NSCLC. |
| Hemoptysis without collapse – Incorrect; SCLC often presents with obstructive signs. |
| Asymptomatic pleural effusion – Incorrect; less characteristic of central SCLC. |
| Q4: First-line treatment for extensive-stage SCLC |
|---|
| Combination chemotherapy ± radiation – Mainstay due to rapid growth and early metastasis. Reference: NCCN Guidelines, 2024 |
| Surgical lobectomy – Incorrect; rarely indicated due to central location and metastasis. |
| Targeted EGFR inhibitor – Incorrect; SCLC typically lacks actionable EGFR mutations. |
| Observation – Incorrect; untreated SCLC rapidly fatal. |
| Q5: Imaging feature to distinguish atelectasis vs effusion |
|---|
| All of the above – Ipsilateral mediastinal shift, vessel crowding, and diaphragm elevation indicate volume loss from atelectasis. Reference: Fraser & Pare, *Diagnosis of Diseases of the Chest*, 5th Edition, 2017 |
| Other individual options – Partially correct but combined signs confirm atelectasis. |
| Q6: Imaging feature of central obstructing mass |
|---|
| Ipsilateral hemithorax opacification with volume loss – Classic radiographic appearance of complete lung collapse due to central SCLC. Reference: Dr. Michael A. Chansky, Medscape, 2025 |
| Peripheral ground-glass opacity – Incorrect, more typical of early interstitial disease. |
| Focal pleural thickening – Incorrect, nonspecific and peripheral. |
| Bilateral interstitial markings – Incorrect, suggests pulmonary edema or fibrosis. |
| Q7: Biomarker supporting SCLC diagnosis |
|---|
| Neuron-specific enolase (NSE) – Sensitive marker for neuroendocrine tumors including SCLC. Reference: Travis et al., WHO Classification of Tumours, 2021 |
| CEA – Incorrect, more common in adenocarcinoma. |
| CA 19-9 – Incorrect, associated with pancreatic/gastrointestinal tumors. |
| AFP – Incorrect, associated with germ cell tumors and hepatocellular carcinoma. |